Insider Trading History of Rome Zachary

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Rome Zachary since 2022. This trader's CIK number is 1809611. At the time of last reporting, Rome Zachary was the Officer of Paxmedica, Inc.. (stock ticker symbol PXMD). Also see all insider trading activities at Paxmedica, Inc..

Note that in the past Rome Zachary also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Timber Pharmaceuticals, Inc. (TMBR) by Rome Zachary

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 TMBR 0 $0 0 $0 79,326 $793

Yearly summary of insider trading at Paxmedica, Inc. (PXMD) by Rome Zachary

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 PXMD 0 $0 811 $389 0 $0
2023 PXMD 0 $0 162,849 $189,113 0 $0


Insider trading activities at 2 companies by Rome Zachary:

1. Timber Pharmaceuticals, Inc. (TMBR)

2. Paxmedica, Inc. (PXMD)

Table 1. Insider trading of Timber Pharmaceuticals, Inc. (TMBR) by Rome Zachary

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-03-04 TMBR Option Ex 79,326 .01 793

Table 2. Insider trading of Paxmedica, Inc. (PXMD) by Rome Zachary

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-01-29 PXMD Sale 811 .48 389
2023-10-27 PXMD Sale 16,301 .18 3,015
2023-08-21 PXMD Sale 20,000 .58 11,620
2023-08-22 PXMD Sale 30,000 .54 16,230
2023-03-08 PXMD Sale 30,034 1.47 44,149
2023-03-09 PXMD Sale 3,371 1.44 4,854
2023-03-06 PXMD Sale 13,560 1.72 23,323
2023-03-07 PXMD Sale 23,432 1.53 35,850
2023-03-02 PXMD Sale 12,952 1.94 25,126
2023-03-03 PXMD Sale 13,199 1.89 24,946

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rome Zachary (Officer of Paxmedica, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.